Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of PVT-1 Treatment in Patients With Advanced and Refractory Non-Small Cell Lung Cancer

NCT04840004 is registered in ClinicalTrials.gov with PlusVitech S.L. as lead sponsor.

NCT NCT04840004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04840004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of PVT-1 Treatment in Patients With Advanced and Refractory Non-Small Cell Lung Cancer
Lead sponsor
PlusVitech S.L.
Phase
Phase 2
Overall status
Unknown status
Start date
March 10, 2021
Completion date
December 31, 2025
Enrollment
24 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, non small cell lung cancer, refractory cancer